Consumer Health

Value sales of sports nutrition are negligible and it is not expected that the situation will change over the forecast period.

Rising inflation has caused consumers to be increasingly stressed in 2023, with rising price points and ongoing economic uncertainty negatively impacting lives. This ongoing uncertainty has led to an increase in physical discomforts; often in the…

Analgesics is recording another strong year of current value growth in 2023, albeit at a slower rate than in 2022. Growth is particularly dynamic in the paediatric segment, especially for acetaminophen and ibuprofen, driven by the outbreak of…

In 2023, increased socialising and the return to post-pandemic habits support the growth of several OTC categories. However, high inflation and a fluctuating exchange rate continue to create uncertainty. Inflation in Costa Rica was 8.27% in 2022, the…

In 2023, consumer health products in Jordan are witnessing notable changes driven by a combination of factors. The industry has experienced a decline from its peaks in 2020 and 2021 when Jordanians rushed to purchase OTC products like analgesics and…

Consumer health continues to experience high retail current value growth in 2023, albeit at a slower rate than 2022. Higher costs of materials, ingredients and services are naturally leading to strong price increases in 2023, thereby driving up value…

At the end of 2022, there was an increase in the need to treat cold and flu symptoms. This was driven by the return of socialising following periods of social distancing, increased hand washing and the wearing of face masks throughout most of 2020…

Current value sales of cough, cold and allergy (hay fever) remedies rebounded to pre-pandemic levels in 2022 as the UK experienced its strongest cold and flu season in recent years, as a result of greater socialising as restrictions eased, thereby…

As consumers face stress due to economic uncertainty and skin imbalances after COVID-19, many suffer from hair loss, helping category growth. While some consumers opt for dietary supplements to avoid hair loss, others turn to shampoos or other…

Demand for hair loss treatments is declining in 2023 following strong growth in recent years as COVID-19 and subsequent inflationary pressure boosted prevalence of hair loss due to stress and anxiety. Although the latter remains an overbearing issue…

Omega-3 supplements have gained immense popularity in Costa Rica due to the growing awareness among people about their health benefits. Omega-3 fatty acids are considered essential nutrients that cannot be produced by the body, and are therefore…

Women’s health has become a key brand focus for players in 2023, across a range of consumer health categories, particularly dietary supplements. Regarded by many as a theme rather than category or positioning, the concept is influencing activity and…

In 2023, consumers are enjoying their newfound freedom following the loosening of COVID-19 restrictions. As such, this has led to an increased use of foodservice, with consumers eating out at restaurants, having parties, and drinking with friends.…

Value sales of digestive remedies are recording another year of strong growth in 2023 as the category continues to benefit from consumers returning to post-pandemic life. For example, antacids is profiting from consumers socialising and drinking more…

Eye health is experiencing another year of double-digit current value growth in 2023, albeit at a marginally slower rate than 2022. Nevertheless, overall demand continues to rise. While there are no lockdown restrictions in place, the pandemic has…

"Macrobioticas" or health food stores, can be found nationwide, and in some parts of the country, their presence is even more visible than that of pharmacies. Traditional healers, known as curanderos or yerberos, are often consulted for advice and…

Herbal/traditional products is experiencing another year of double-digit current value growth in 2023. Ingredient-led purchases are becoming increasingly common among local consumers, not only due to growing awareness of the benefits of certain…

Demand for NRT smoking cessation aids is declining in 2023, despite a further drop in smoking prevalence among the adult population as consumers continue to focus on their health post-pandemic. A marginal decline in retail volume sales is likely to…

There is a growing demand for natural and organic products in all categories regarding paediatric health. This is increasingly obvious in baby food, supplements, and skin care products. Parents are becoming more conscious of the ingredients in the…

Paediatric consumer health in the UK is witnessing another strong year of current value growth in 2023, albeit at a slower pace than 2022. The positive performance across both years has predominantly been driven by high growth for paediatric cough,…

Current value sales of sleep aids continue to rise in 2023, albeit at a slower rate due to stocking up and strong sales over the last three years since the emergence of the pandemic. Local consumers continue to experience the cost-of-living crisis in…

Sports nutrition witnessed an upturn in current value sales in 2022 as consumers left COVID-19 fears behind and returned to gyms and their usual sporting activities. Moving into 2023, Many Costa Ricans focus on losing weight gained during the…

After a marginal decline in the first year of the pandemic, sports nutrition in the UK continues to record strong current value sales growth in 2023, following a full recovery in 2021. Apart from the price hikes driven by inflation since the end of…

Consumers having less disposable income has impacted their purchasing habits in 2023, including their choices regarding healthcare products and vitamins. Rather than investing in preventative measures like vitamins, consumers are opting for more…

Value sales of vitamins have rebounded in 2023, recording growth for the first time since 2021. Although value growth is much weaker than at the height of the pandemic, and overall retail volume sales are continuing to decline, demand remains above…

During 2022 and 2023, Ozempic injections have started to be used by consumers who do not have type 2 diabetes to lose weight. Popularised by international media, higher-income consumers who can afford them have resorted to using these injections to…

Weight management and wellbeing continues to experience strong value growth in 2023, as the general health and wellness trend remains prevalent post-pandemic. As consumers have returned to hectic routines with the reopening of offices, balancing a…

The growth of sports and indoor and outdoor activities, as well as children returning to school, has led to increased injuries compared to the previous years of COVID-19 restrictions. This, in turn, has driven the demand for first aid products in…

With a lack of new product development and brand activity in 2023, demand for wound care is being primarily driven by a full year without lockdown restrictions boosting out-of-home activities. The category’s performance is largely dependent on…

While analgesics are expected to register double-digit current value growth, constant value and volume growth is expected to be much more moderate, as inflation continues to be high. Any growth there is Chufa supported by population growth, as well…

Retail volume sales of analgesics rebounded in 2023, following a two-year period of decline. While the COVID-19 pandemic boosted demand for acetaminophen (paracetamol), which was the only analgesic recommended by the government to alleviate the…

Sales of analgesics are seeing robust growth in current value terms in 2023, continuing on from the steady performance seen in 2022. During 2022, sales of analgesics benefited from a sudden peak in cases of flu in the middle of the winter. This was…

While analgesics performed well during the pandemic, they has returned to more moderate growth now that the threat has subsided. In 2023, analgesics is expected to register moderate current value growth, though constant value sales are expected to…

Analgesics achieved strong double-digit growth in 2023 amidst stable consumer demand and rising unit prices caused by inflation. Systemic analgesics is outperforming topical analgesics in 2023, a trend that has been prevalent throughout the review…

Systematic analgesics is expected to register positive retail value (constant 2023 prices) growth over 2023, after a spike in 2022 driven by very strong demand for paediatric analgesics, as well as fast demand for adult pain relief, as respiratory…

In 2023, acetaminophen continues to lead sales of analgesics in Chile, whilst also experiencing the highest growth rate in the category. This growth has remained steady since the onset of the pandemic, where acetaminophen became the preferred choice…

Even after seeing exceptional current value growth in 2022, it is anticipated that analgesics will continue to experience double-digit growth in 2023. This can primarily be attributed to the substantial increase in COVID-19 cases in China starting…

After the spike in demand for systemic analgesics in the period, 2020 to 2021, driven by COVID-19 and then by the need to relieve reactions to vaccination, in 2022 demand tended to stabilise. However, adult acetaminophen and combination analgesics…

Growth of analgesics in 2023 can be mainly attributed to the full recovery of daily activity post pandemic. The main contributors here were the full operation of manual labour intensive industries (predominantly construction), a stronger flu season…

Following strong growth between 2020 and 2022, analgesics saw much more moderate current value growth in 2023 as the COVID-19 pandemic began to wane. Rising inflation as a result of the energy crisis stemming in part from the war in Ukraine is…

Analgesics has not seen a positive performance in 2023 as the height of the pandemic has passed. During the pandemic’s peak, consumers were buying up analgesics at a rapid pace to treat fevers, aches and other symptoms associated with acute…

Pharmacies continue to have significant influence over the value sales of analgesics in Ecuador. For instance, in lower income neighbourhoods, pharmacies are generally stocked with generics, whereas in wealthier neighbourhoods, mainly branded…

Value sales of analgesics in France continue to record solid growth in 2023 following a dynamic performance the previous year. The key growth driver is the increasing demand for acetaminophen, with the brand Doliprane from Sanofi, convincingly…

Upon the lifting of all COVID-19 related regulations, including the compulsory use of face masks, social distancing rules and compulsory self-isolation, there has been a surge in illness which has been a major contributor to sales growth for…

Analgesics sales are returning to more normal patterns in 2023, following the fluctuations caused by the COVID-19 pandemic and the sharp price rises seen in 2022. On balance, current value growth rates are still elevated compared to pre-pandemic…

The return to normal lifestyles out of the home is driving retail volume and current value sales of analgesics in 2023. Adults and children alike are more exposed to common colds and viruses requiring pain relief. Children in school are no longer…

Analgesics is expected to see a single-digit growth in current value terms in 2023. Sales are benefiting from the stable demand for analgesics and unit price increases linked to rising price lists as a result of the higher cost of production faced by…

Analgesics in Morocco has continued to develop positively in 2023, with total current value sales set to grow at a faster rate than in 2022 and most categories expected to post improved results in volume terms. Together with population growth and…

Per capita consumption of analgesics continued to increase in Norway during 2023 after 2022 saw significant increases in consumption of these products. While there was some stockpiling of analgesics seen in Norway during the early stages of the…

While most categories of analgesics are set to witness decreases in retail volume sales over 2023, this is largely due to spikes in sales in the wake of the Coronavirus (COVID-19) pandemic as stress and anxiety levels increased. In 2023, many…